On May 3rd 2023, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. The company’s robust growth in 2022 and the successful spin off of Inify Laboratories AB has resulted in a strong balance sheet. In the light of this background and in line with the board’s recommendation, the Meeting resolved on a dividend […]
STOCKHOLM – March 30, 2023 – ContextVision hereby invites shareholders to the Annual General Meeting on May 3, 2023. Please find attached the invitation including agenda and details on how to register and vote. Please contact: for any questions regarding the AGM. For inquiries, please contact CFO Markus Hökerberg E-mail:
STOCKHOLM – March 30th, 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today presents their Annual Report for 2022. The Annual Report gives additional information about the record year, where net sales increased by 20% compared to 2021, and EBITDA ended at 49 MSEK or 42%. 2022 was […]
STOCKHOLM – Feb 16, 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today reports its fourth quarter results. Net sales record The company delivers another record quarter with a net sales of SEK 32.6 M, an increase of 19%. For the full year, net sales increased 20% to […]
ContextVision Showcases Latest Image Enhancement, Accelerates Growth Globally with Focus on Core Offerings. ContextVision, a medical technology software company specializing in image quality, will be highlighting its comprehensive suite of image enhancement solutions aimed at improving patient diagnoses at RSNA 2022.
Gerald Pötzsch, CEO of ContextVision, has during the period of August 31st until November 1st, 2022 purchased 10.000 shares in ContextVision AB at an average price of NOK 8,71 per share. After the transaction, Mr Pötzsch holds a total of 15.000 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the […]